A New VISTA on combination therapy for negative checkpoint regulator blockade. - Wikidata - wikimedia - TriplyDB

A New VISTA on combination therapy for negative checkpoint regulator blockade.

A New VISTA on combination therapy for negative checkpoint regulator blockade.

http://www.wikidata.org/entity/Q37517581

about

Delivering safer immunotherapies for cancer.Immune checkpoint blockade in infectious diseases.Inhibitors of the PD-1 Pathway in Tumor Therapy.

P2860

Q39330984-DD94EA36-7F56-40BA-88CE-FF41AA1B62F5 Q41921732-F489A5B2-E5A8-4754-9AA3-12E289436903 Q48293633-11EE63C0-C7B3-4A32-8ED5-BEBA7D482499

P2860

A New VISTA on combination therapy for negative checkpoint regulator blockade.

http://www.wikidata.org/entity/Q37517581

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@en

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@nl

type

label

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@en

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@nl

prefLabel

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@en

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@nl

P1433

Q37517581-DA001FA8-15F9-47E1-B245-9519D9549D17

P1476

Q37517581-039D3E54-2326-48B2-BB15-3847E592DC47

P2093

Q37517581-6F494783-A9DE-4551-B9A5-9D9107DBBE25

Q37517581-93ACE7A1-DBCE-4BCD-A9B6-331944400C5B

Q37517581-CD3A935C-99B1-4AE9-B33E-244FF2C6BD9E

Q37517581-CE46D6D2-2A0D-4A6F-A6E9-F04ED431E633

P2860

Q37517581-05465061-62DA-4BFE-A3F1-2F00D4039621

Q37517581-07F078CA-E900-4414-935A-2F222D3C538A

Q37517581-0850E6A9-D1F6-4BC9-9ED7-C0446AC61BB9

Q37517581-0E0E4141-7DCD-4FAD-BAD0-5CCEA937BBC9

Q37517581-0F5B5A15-27C6-4105-A72B-8C303235DDEF

Q37517581-10C19EA8-B259-4386-9925-F7CE61671B02

Q37517581-154980E0-6493-4AA2-9C35-A756AA20A5C3

Q37517581-159F9A9D-12EB-40F0-944F-68FC34862C36

Q37517581-16D5B0D2-8E0A-4860-9A36-BCAC89F8E770

Q37517581-1958444F-04A1-4724-86E1-2799B242D72C

P2888

Q37517581-7F430C5D-BA39-4035-AF9B-18752DD5EB4D

P304

Q37517581-273CBEBC-4A51-4627-B94D-B20CF282C537

P31

Q37517581-AA539CBB-F122-4C55-882A-6D28E5C2A7BE

P356

Q37517581-9258804C-DBF1-4794-B7AF-3900C55D3418

P478

Q37517581-ABDEA347-1C6B-436D-A1E5-1898EA7A07F0

P577

Q37517581-E01E24F0-555B-4180-9C35-4E876DA1EE52

P6179

Q37517581-809A5E7A-1921-4DE7-B6C7-C0059FAA733D

P698

Q37517581-94C900E7-8944-48D7-890E-568B93BB54B0

P932

Q37517581-7D6D955F-E632-451C-9B87-2120E21BB888

P356

S40425-016-0190-5

P1433

Journal for Immunotherapy of Cancer

P1476

A New VISTA on combination therapy for negative checkpoint regulator blockade.

@en

P2093

Anna Kuta

http://www.w3.org/2001/XMLSchema#string

Isabelle Le Mercier

http://www.w3.org/2001/XMLSchema#string

Jie Deng

http://www.w3.org/2001/XMLSchema#string

Randolph J Noelle

http://www.w3.org/2001/XMLSchema#string

P2860

CD28/B7 system of T cell costimulation

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators

Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma

Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues.

Nivolumab plus ipilimumab in advanced melanoma.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

P2888

s40425-016-0190-5

P304

86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40425-016-0190-5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046305064

http://www.w3.org/2001/XMLSchema#string

P698

28031817

http://www.w3.org/2001/XMLSchema#string

P932

5168856

http://www.w3.org/2001/XMLSchema#string